Tarsus Pharmaceuticals Inc (TARS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -66,418 | -115,554 | -135,893 | -62,091 | -13,827 |
| Depreciation Amortization | -3,073 | -2,506 | -1,901 | -681 | 606 |
| Accounts receivable | -38,297 | -30,139 | -16,621 | N/A | N/A |
| Accounts payable and accrued liabilities | 6,906 | 2,544 | 4,537 | N/A | N/A |
| Other Working Capital | 14,638 | 3,844 | 306 | -951 | 1,372 |
| Other Operating Activity | 73,793 | 58,784 | 32,079 | 14,693 | 15,597 |
| Operating Cash Flow | $-12,451 | $-83,027 | $-117,493 | $-49,030 | $3,748 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9,859 | -1,567 | -1,502 | -506 | -586 |
| Purchase Of Investment | -394,056 | -265,628 | -28,664 | -149,438 | N/A |
| Sale Of Investment | 361,800 | 73,000 | 174,770 | 5,315 | N/A |
| Purchase Sale Intangibles | 0 | -5,000 | -4,000 | 0 | N/A |
| Other Investing Activity | 0 | -5,000 | -4,000 | 0 | 0 |
| Investing Cash Flow | $-42,115 | $-199,195 | $140,604 | $-144,629 | $-586 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 75,000 | 10,000 | 20,000 | N/A |
| Debt Repayment | 0 | -31,877 | 0 | N/A | N/A |
| Common Stock Issued | 143,388 | 115,056 | 120,176 | 74,937 | 324 |
| Other Financing Activity | 0 | -3,523 | 0 | -950 | -303 |
| Financing Cash Flow | $143,388 | $154,656 | $130,176 | $93,987 | $21 |
| Beginning Cash Position | 97,381 | 224,947 | 71,660 | 171,332 | 168,149 |
| End Cash Position | 186,203 | 97,381 | 224,947 | 71,660 | 171,332 |
| Net Cash Flow | $88,822 | $-127,566 | $153,287 | $-99,672 | $3,183 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,451 | -83,027 | -117,493 | -49,030 | 3,748 |
| Capital Expenditure | -9,859 | -1,567 | -1,502 | -506 | -586 |
| Free Cash Flow | -22,310 | -84,594 | -118,995 | -49,536 | 3,162 |